Stock Events

Stock Events

Canntab Therapeutics 

€0.007000
0
-€0.00-0% Friday 20:00

Statistics

Day High
0.007
Day Low
0.007
52W High
0.007
52W Low
0.007
Volume
5,500
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Apr 16
€0.01
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Charlottes Web
CWBHF
Mkt Cap89.82M
Charlotte's Web holdings produce CBD oil and extracts, competing with Canntab in the wellness segment of cannabinoid products.
Cronos Group
CRON
Mkt Cap1.25B
Cronos Group is involved in the production and sale of cannabis in various forms, a direct market competitor in the cannabis industry.
Tilray Brands
TLRY
Mkt Cap631.5M
Tilray produces medical cannabis products, directly competing with Canntab in the medical cannabis market.
Aurora Cannabis
ACB
Mkt Cap253.87M
Aurora Cannabis is a well-known producer and distributor of medical cannabis, competing in the same industry as Canntab.
Canopy Growth
CGC
Mkt Cap449.07M
Canopy Growth Corporation is a diversified cannabis and cannabinoid-based consumer product company competing across similar markets as Canntab.

About

Canntab Therapeutics Limited, a phytopharmaceutical company, engages in the research and development of advanced pharmaceutical grade formulations of cannabinoids in Canada. It offers oral dosage formulations of pharmaceutical cannabis, including sustained release cannabinoid formulations and pellets, immediate release cannabidiol formulations, modified-release multi-layer cannabinoid formulations, flash-melt cannabinoid formulations, and bi-layer cannabinoid tablets for treating sleep disorders, post-traumatic stress disorder, social anxiety, addiction, arthritis, general pain, pain management and appetite loss associated with cancer treatments, and addiction treatment therapy of opioids and other painkillers. Canntab Therapeutics Limited is headquartered in Markham, Canada.
Show more...
CEO
Mr. Richard C. Goldstein
Country
Canada
ISIN
CA1377991023
WKN
000A2JKBY

Listings

MU
DE
TBF1.MU
STU
DE
TBF1.STU

0 Comments

Share your thoughts

FAQ

What is Canntab Therapeutics stock price today?▼
The current price of TBF1.MU is €0.01 EUR — it has decreased by -0% in the past 24 hours. Watch Canntab Therapeutics stock price performance more closely on the chart.
What is Canntab Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Canntab Therapeutics stocks are traded under the ticker TBF1.MU.
Does Canntab Therapeutics pay dividends?▼
Yes, TBF1.MU dividends are paid annual. The last dividend per share was 0.01 EUR. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Canntab Therapeutics located?▼
Canntab Therapeutics operates in the Health & Wellness sector.
When did Canntab Therapeutics complete a stock split?▼
Canntab Therapeutics has not had any recent stock splits.
Where is Canntab Therapeutics headquartered?▼
Canntab Therapeutics is headquartered in Markham, Canada.